Vaxxinity (VAXX) Institutional Ownership $0.0002 0.00 (0.00%) (As of 11:50 AM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Vaxxinity (NASDAQ:VAXX)CurrentInstitutional OwnershipPercentage82.95%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$70.77KNumber ofInstitutional Sellers(last 12 months)0 Get VAXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxxinity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VAXX Institutional Buying and Selling by Quarter Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Vaxxinity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/7/2024 Ieq Capital LLC83,262$71K0.0%N/A0.066% 11/7/2023 New York State Common Retirement Fund23,642$32K0.0%-46.4%0.019% 10/31/2023 McAdam LLC68,281$94K0.0%+47.4%0.054% 10/24/2023 Bank of New York Mellon Corp121,522$166K0.0%-14.8%0.096% 10/19/2023 Clarius Group LLC20,000$27K0.0%N/A0.016% 8/4/2023 American International Group Inc.20,514$52K0.0%N/A0.016% 7/25/2023Raymond James Financial Services Advisors Inc.17,001$43K0.0%+69.7%0.013% 5/3/2023 Integrated Wealth Concepts LLC11,000$25K0.0%N/A0.009% 5/2/2023 Lincoln National Corp41,070$93K0.0%N/A0.033% 5/1/2023Virtu Financial LLC12,263$28K0.0%-31.3%0.010% 4/24/2023 McAdam LLC46,324$105K0.0%N/A0.037% 4/21/2023 Blue Zone Wealth Advisors LLC27,500$62K0.0%N/A0.022% 4/18/2023ETF Managers Group LLC43,836$100K0.0%+39.5%0.035% 3/23/2023ETF Managers Group LLC31,427$44K0.0%-15.5%0.025% 11/15/2022Prime Movers Lab LLC17,603,276$31.37M22.6%-1.4%13.968% 11/4/2022First Republic Investment Management Inc.199,022$394K0.0%N/A0.158% 8/10/2022 Clarius Group LLC20,000$31K0.0%N/A0.016% 7/22/2022 Truist Financial Corp20,738$33K0.0%N/A0.016% 7/21/2022 Hollencrest Capital Management20,000$31K0.0%N/A0.016% 3/10/2022Prime Movers Lab LLC18,027,314$91.02M17.4%N/A14.377% 2/15/2022 Adage Capital Partners GP L.L.C.1,001,670$5.62M0.0%N/A0.799% 2/14/2022ETF Managers Group LLC37,884$211K0.0%N/A0.030% 2/1/2022FNY Investment Advisers LLC4,847$27K0.0%N/A0.004% (Data available from 1/1/2016 forward) VAXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VAXX shares? During the previous two years, 12 institutional investors and hedge funds held shares of Vaxxinity. The most heavily invested institutionals were Bank of New York Mellon Corp ($166K), ETF Managers Group LLC ($100K), McAdam LLC ($94K), Lincoln National Corp ($93K), Ieq Capital LLC ($71K), Blue Zone Wealth Advisors LLC ($62K), and American International Group Inc. ($52K).Learn more on VAXX's institutional investors. What percentage of Vaxxinity stock is owned by institutional investors? 82.95% of Vaxxinity stock is owned by institutional investors. Learn more on VAXX's institutional investor holdings. Which institutional investors have been buying Vaxxinity stock? Of the 9 institutional investors that purchased Vaxxinity stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Ieq Capital LLC ($83.26K), McAdam LLC ($68.28K), Lincoln National Corp ($41.07K), Blue Zone Wealth Advisors LLC ($27.50K), American International Group Inc. ($20.51K), Clarius Group LLC ($20K), and ETF Managers Group LLC ($12.41K). How much institutional buying is happening at Vaxxinity? Institutional investors have bought a total of 291,021 shares in the last 24 months. This purchase volume represents approximately $511.50K in transactions. Which Vaxxinity major shareholders have been selling company stock? The following institutional investors have sold Vaxxinity stock in the last 24 months: Bank of New York Mellon Corp ($21.19K), New York State Common Retirement Fund ($20.46K), ETF Managers Group LLC ($5.76K), and Virtu Financial LLC ($5.58K). How much institutional selling is happening at Vaxxinity? Institutional investors have sold a total of 52,992 shares in the last 24 months. This volume of shares sold represents approximately $77.79K in transactions. Related Companies Evelo Biosciences Institutional Ownership eFFECTOR Therapeutics Institutional Ownership Alvotech Institutional Ownership LAVA Therapeutics Institutional Ownership This page (NASDAQ:VAXX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxxinity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
